Navigation Links
Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
Date:8/18/2008

BOSTON, Aug. 18 /PRNewswire-USNewswire/ -- Boston University and Aubrey Milunsky, MB.B.Ch, D.Sc., President of the Center for Human Genetics, Inc. ("CHG") and Director of the Center for Human Genetics of Boston University, announced that CHG will no longer offer testing services covered by patents licensed to Athena Diagnostics, Inc.

These patented tests include tests relating to: CADASIL, hearing loss related to A1555G or Connexin 26 mutations, developmental disorders caused by mutation of the ARX gene, Duchene's muscular dystrophy, myotonic dystrophy (DM1), Freidreich's Ataxia (FRDA), hereditary neuropathy with pressure palsies, polycystic kidney disease, spinal muscular atrophy (SMN1), spinocerebellar ataxia (SCA1, 2, 3, 6, 7 and 8) and tuberous sclerosis (type 2). This decision follows a negotiated settlement agreement with Athena, which had brought the issue to the attention of the University and CHG. Athena has made no objection to, and the settlement does not affect any non-commercial research activities at Boston University.

Much of the technology underlying these testing services was discovered by academic scientists, patented by their respective universities, and licensed to Athena Diagnostics for commercial development of diagnostic testing services. Boston University respects intellectual property rights.

The Center for Human Genetics, Inc. has advised its clients that it will henceforth either forward any future request for an Athena-licensed testing service to Athena for processing, or notify the requesting client that it may procure the services directly from Athena.

Massachusetts-based Athena makes available a wide range of more than 200 testing services, for a variety of neurological, endocrine, and renal disorders with genetic or other etiologies.


'/>"/>
SOURCE Boston University
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Designers of primary cell ... solution size by 50% and extend battery life with ... management integrated circuit (PMIC) from Maxim Integrated Products, Inc. ... a low input voltage of just 0.7V for new ... Silver Oxide, as well as the more common Alkaline ...
(Date:3/29/2017)... KALAMAZOO, Michigan , USA, March 29, 2017 /PRNewswire/ ... a Company that Cares by People magazine, in partnership ... out of 50 companies on the list. This list ... employees that have succeeded in business while also demonstrating ... and the environment.  To determine the ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ - Medicure Inc. ... release financial results for the year ended December ... 26, 2017. The results are being released later ... financial statements will include the operations and balances ... 1, 2016.  This release and filing date meets ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 2017 , ... Tuesday, March 28, 2017, is the annual American Diabetes Association ... Test to find out if they are at risk for developing Type 2 diabetes. ... evening sky by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower ...
(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth ... Congress to protect parental rights and civil liberties, and to restore transparency within ... The demonstration coincides with a press conference taking place Friday morning calling on ...
(Date:3/28/2017)... (PRWEB) , ... March 28, ... ... a non-profit medical society dedicated to advancing the science and clinical practice ... from its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize ...
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival of warmer ... for those self-conscious about a double chin, this means more anxiety than elation. The ... , “For most people, a double chin is undesirable,” Dr. Goldman said, “but it ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... announced the release of two biometric time and attendance tracking products: the new ... software. NCheck Cloud Bio Attendance uses biometric face recognition to enable users ...
Breaking Medicine News(10 mins):